TELA Bio (TELA) Change in Cash (2018 - 2026)
TELA Bio's (TELA) quarterly Change in Cash came in at -$11.3 million in Q1 2026, down 14.91% year-on-year from -$13.3 million in Q1 2025, and down 153.49% quarter-over-quarter from $21.1 million in Q4 2025.
TELA Bio (TELA) Change in Cash (2018 - 2026) Analysis & Trends
TELA Bio's Change in Cash history runs 9 years deep, the most recent figure standing at -$11.3 million for Q1 2026.
- On a quarterly basis, Change in Cash fell 14.91% year-over-year to -$11.3 million in Q1 2026; TTM through Mar 2026 was -$3.3 million, a 158.12% decrease from a year earlier, with the FY2025 full-year figure at -$1.8 million, down 130.97% from the prior year.
- Change in Cash retreated to -$11.3 million in Q1 2026 per TELA's latest filing, from $21.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $35.4 million in Q4 2024 and bottomed at -$12.2 million in Q4 2022.
- The 5-year median for Change in Cash is -$9.2 million (2024), against an average of -$243529.4.
- Across the five-year window, Change in Cash surged 764.18% in 2023 and plunged 130.3% in 2024, its largest moves.
- Year by year, Change in Cash stood at -$12.2 million in 2022, then gained by 8.18% to -$11.2 million in 2023, then surged by 415.57% to $35.4 million in 2024, then slumped by 40.25% to $21.1 million in 2025, then sank by 153.49% to -$11.3 million in 2026.
- Per Business Quant, the three latest TELA Change in Cash figures stand at -$11.3 million (Q1 2026), $21.1 million (Q4 2025), and -$5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 199.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | -2.23 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | -282.15 Mn |
| 10 | TELA Bio | 38.25 Mn | -1.29 Mn | 12.52 Mn | -11.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.30 Mn |
| Dec 31, 2025 | 21.13 Mn |
| Sep 30, 2025 | -5.28 Mn |
| Jun 30, 2025 | -7.86 Mn |
| Mar 31, 2025 | -9.84 Mn |
| Dec 31, 2024 | 35.37 Mn |
| Sep 30, 2024 | -9.20 Mn |
| Jun 30, 2024 | -10.65 Mn |
| Mar 31, 2024 | -9.59 Mn |
| Dec 31, 2023 | -11.21 Mn |
| Sep 30, 2023 | -7.06 Mn |
| Jun 30, 2023 | 35.14 Mn |
| Mar 31, 2023 | -11.90 Mn |
| Dec 31, 2022 | -12.21 Mn |
| Sep 30, 2022 | 26.50 Mn |
| Jun 30, 2022 | -5.29 Mn |
| Mar 31, 2022 | -10.92 Mn |
| Dec 31, 2021 | -9.71 Mn |
| Sep 30, 2021 | -6.66 Mn |
| Jun 30, 2021 | -5.54 Mn |